(Q48628550)

13 February 2018

title

Oligodeoxynucleotides induce brain inflammation in rats when infused intracerebroventricularly (English)

1 reference

13 February 2018

1 reference

4

Hans-Dieter Volk

1 reference

13 February 2018

author name string

Peter Elepfandt

1

1 reference

13 February 2018

Stefan Rupprecht

2

1 reference

13 February 2018

Britta Schöning-Burkhardt

3

1 reference

13 February 2018

Christian Woiciechowsky

5

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 April 2002

1 reference

13 February 2018

published in

Neuroscience Letters

1 reference

13 February 2018

volume

322

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

107-110

1 reference

13 February 2018

Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Chemokine inhibition in rat stab wound brain injury using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

The use of in vivo antisense oligonucleotide technology for the investigation of brain GABA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: some prospects and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Antisense oligodeoxynucleotide attenuates in vivo expression of c-fos in the paraventricular hypothalamic nucleus of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900093-9

7 January 2021

10.1016/S0304-3940(02)00093-9

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018